Equifax Inc. (EFX) is one of the three dominant U.S. credit bureaus, alongside Experian and TRU (TransUnion). After peaking near $271.84 over the past year, the stock has slid to roughly $186, leaving investors to ask whether it can climb back toward the round-number $250 mark. That level is notable because it sits between the current price and the recent high, representing a roughly 34% gain that would require both fundamental improvement and a meaningful shift in market sentiment.
Equifax is a data, analytics, and technology company operating through three segments: Workforce Solutions, which provides income and employment verification through offerings such as The Work Number (TWN); U.S. Information Solutions (USIS), which includes credit information, scoring, and fraud-prevention products; and International. The company generated trailing twelve-month revenue of about $6.44 billion, growing more than 10% year over year, and carries a market capitalization near $21.9 billion.
The stock trades at a trailing price-to-earnings (P/E) ratio of roughly 33, above the broader professional services industry average and a notable premium to peers. A forward P/E near 20 reflects expectations for earnings growth. The company also pays a quarterly dividend yielding just over 1%.
The bullish case centers on execution and product innovation. Equifax posted adjusted earnings per share (EPS) of $2.25 in its most recent quarter, topping the roughly $2.20 consensus estimate, with revenue of about $1.7 billion. Analysts have pointed to improving delivery on cloud- and AI-driven initiatives, and to traction from bundled TWN solutions in mortgage lending that could eventually be replicated across auto and personal loans.
Notably, one firm upgraded the stock from Neutral to Buy in recent months, lifting its price target to $235 and citing easier growth comparisons versus its two credit-bureau peers. Cost-reduction programs, share buybacks, and new contract wins have also been cited as supportive factors for margins and shareholder returns.
Several hurdles stand between Equifax and a $250 price tag. The stock still carries a premium valuation, and long-term shareholders have endured a difficult stretch, with the share price down materially over a multi-year window even as earnings-based multiples sit close to or above peer averages. A proposed $100 million settlement tied to past credit-score errors, while potentially drawing a line under one legal issue, underscores ongoing regulatory and reputational risk.
There are also softer pockets in the business. Government verification revenue declined modestly in a recent period, and contract roll-offs have created modest headwinds to organic growth in core non-mortgage credit products. These factors have prompted several analysts to trim their price targets, even while maintaining Buy or Outperform ratings.
Wall Street's stance on Equifax remains broadly constructive, with an average rating in the Buy-to-Outperform range. However, the consensus twelve-month price target of roughly $211 to $215 sits well below $250, implying upside of only about 13% to 15% from current levels. Individual targets span a wide range: more conservative estimates cluster near $179 to $194, while several firms hold targets of $225 to $245, and the highest estimates reach toward $266.
That dispersion matters. Reaching $250 would require the stock not only to hit the average analyst target but to exceed it by roughly 15%, effectively matching the top end of current coverage. It is achievable, but it is not the base-case scenario embedded in consensus estimates.
From a technical analysis standpoint, the stock's descent from the $271.84 high has left several layers of overhead supply. The area around $225 to $235, which previously acted as support, now represents a resistance zone the stock would likely need to reclaim. Above that sits the psychological $250 level, which would be the final milestone in a recovery scenario. On the downside, the $150 to $160 region aligns with the 52-week low and represents the key support area to watch.
For traders looking to monitor whether Equifax can build momentum toward higher price targets, Tickeron's AI Daily Buy/Sell Signals offers an AI-driven tool that continuously scans thousands of stocks and ETFs. The system generates Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and automated analysis, helping users spot opportunities, track existing positions, and identify shifting trends more efficiently. Traders interested in a systematic way to follow changing market dynamics may find these signals a useful complement to their own research.
Equifax reaching $250 is realistic over a multi-quarter or longer horizon, but it is not the consensus expectation today. The strongest supporting factors are accelerating revenue growth, improving cloud and AI execution, margin discipline, and a still-favorable Wall Street stance. The primary risks are a premium valuation, regulatory overhang, and uneven performance in segments such as government verification. Investors should monitor earnings execution, organic growth trends, and whether the stock can first reclaim the $225 to $235 resistance zone before $250 becomes a credible near-term objective.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, EFX has been loosely correlated with TRU. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if EFX jumps, then TRU could also see price increases.
| Ticker / NAME | Correlation To EFX | 1D Price Change % | ||
|---|---|---|---|---|
| EFX | 100% | -0.03% | ||
| TRU - EFX | 65% Loosely correlated | -0.13% | ||
| EXPO - EFX | 56% Loosely correlated | -0.21% | ||
| VRSK - EFX | 50% Loosely correlated | -1.20% | ||
| MSA - EFX | 49% Loosely correlated | -1.91% | ||
| ARLO - EFX | 48% Loosely correlated | -0.99% | ||
More | ||||
| Ticker / NAME | Correlation To EFX | 1D Price Change % |
|---|---|---|
| EFX | 100% | -0.03% |
| Data Processing Services industry (24 stocks) | 21% Poorly correlated | +0.62% |
| Technology Services industry (397 stocks) | -6% Poorly correlated | +0.99% |